Multidrug-Resistant and Extensively Drug-Resistant Enterobacteriaceae: Prevalence, Treatments, and Outcomes – A Retrospective Cohort Study

References

• Exner M, Bhattacharya S, Christiansen B, et al. Antibiotic resistance: what is so special about multidrug-resistant gram-negative bacteria? GMS Hyg Infect Control. 2017;12:Doc05.28451516
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49(2):760–766. doi:10.1128/AAC.49.2.760-766.200515673761
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Abramson MA, Beekmann SE, et al. Antimicrobial resistance among gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol. 2007;45(10):3352–3359. doi:10.1128/JCM.01284-0717715376
   PubMed Web of Science ®Google Scholar
• Gajdács M, Bátori Z, Ábrók M, Lázár A, Burián K. Characterization of resistance in gram-negative urinary isolates using existing and novel indicators of clinical relevance: a 10-year data analysis. Life. 2020;10(2):16. doi:10.3390/life10020016
   PubMedGoogle Scholar
• Parajuli NP, Acharya SP, Mishra SK, Parajuli K, Rijal BP, Pokhrel BM. High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrob Resist Infect Control. 2017;6(1):67. doi:10.1186/s13756-017-0222-z28638594
   PubMed Web of Science ®Google Scholar
• Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassopoulou P, Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) gram-negative bacteria. BMC Infect Dis. 2005;5(1):24. doi:10.1186/1471-2334-5-2415819983
   PubMed Web of Science ®Google Scholar
• Druge S, Ruiz S, Vardon-Bounes F, et al. Risk factors and the resistance mechanisms involved in Pseudomonas aeruginosa mutation in critically ill patients. J Intensive Care. 2019;7(1):36. doi:10.1186/s40560-019-0390-431360523
   PubMed Web of Science ®Google Scholar
• Kollef MH. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis. 2008;47(Suppl S1):S3–S13. doi:10.1086/59006118713047
   PubMed Web of Science ®Google Scholar
• Micek ST, Welch EC, Khan J, et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother. 2010;54(5):1742–1748. doi:10.1128/AAC.01365-0920160050
   PubMed Web of Science ®Google Scholar
• Zowawi HM. Antimicrobial resistance in Saudi Arabia. An urgent call for an immediate action. Saudi Med J. 2016;37(9):935–940. doi:10.15537/smj.2016.9.1613927570847
   PubMed Web of Science ®Google Scholar
• Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America. Clin Infect Dis. 2009;48(1):1–12. doi:10.1086/59501119035777
   PubMed Web of Science ®Google Scholar
• Gajdács M, Albericio F. Antibiotic resistance: from the bench to patients. Antibiotics. 2019;8(3):129. doi:10.3390/antibiotics8030129
   Web of Science ®Google Scholar
• Gajdács M. The concept of an ideal antibiotic: implications for drug design. Molecules. 2019;24(5):892. doi:10.3390/molecules24050892
   PubMed Web of Science ®Google Scholar
• Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82–S89. doi:10.1086/49940616355321
   PubMed Web of Science ®Google Scholar
• Ben-David D, Kordevani R, Keller N, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18(1):54–60. doi:10.1111/j.1469-0691.2011.03478.x
   PubMed Web of Science ®Google Scholar
• Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis. 2002;34(12):1600–1606. doi:10.1086/34061612032895
   PubMed Web of Science ®Google Scholar
• Menashe G, Borer A, Yagupsky P, et al. Clinical significance and impact on mortality of ESBL-producing gram-negative isolates in nosocomial bacteremia. Scand J Infect Dis. 2001;33(3):188–193. doi:10.1080/0036554015106080611303808
   PubMedGoogle Scholar
• Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000;Suppl 31(Supplement_4):S131–S138. doi:10.1086/314079
   Web of Science ®Google Scholar
• Benkő R, Gajdács M, Matuz M, et al. Prevalence and antibiotic resistance of ESKAPE pathogens isolated in the emergency department of a tertiary care teaching hospital in hungary: a 5-year retrospective survey. Antibiotics. 2020;9(9):624. doi:10.3390/antibiotics9090624
   Web of Science ®Google Scholar
• Basak S, Singh P, Rajurkar M. Multidrug resistant and extensively drug resistant bacteria: a Study. J Pathog. 2016;2016:1–5. doi:10.1155/2016/4065603
   Google Scholar
• Gupta V, Ye G, Olesky M, Lawrence K, Murray J, Yu K. National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States. Int J Infect Dis. 2019;85:203–211. doi:10.1016/j.ijid.2019.06.01731229615
   PubMed Web of Science ®Google Scholar
• Alqasim A, Abu Jaffal A, Alyousef A. Prevalence of multidrug resistance and extended-spectrum β-lactamase carriage of clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia. Int J Microbiol. 2018;3026851.
   Google Scholar
• Siwakoti S, Subedi A, Sharma A, Baral R, Bhattarai NR, Khanal B. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study. Antimicrob Resist Infect Control. 2018;7:114. doi:10.1186/s13756-018-0404-330275945
   PubMed Web of Science ®Google Scholar
• Gupta R, Malik A, Rizvi M, et al. Epidemiology of multidrug-resistant gram-negative pathogens isolated from ventilator-associated pneumonia in ICU patients. J Glob Antimicrob Resist. 2017;9:47–50. doi:10.1016/j.jgar.2016.12.01628288860
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO): list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Available from: https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 123, 2020.
   Google Scholar
• Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13(47):19044.19021958
   PubMedGoogle Scholar
• Zhanel GG, DeCorby M, Laing N, et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005–2006. Antimicrob Agents Chemother. 2008;52(4):1430–1437. doi:10.1128/AAC.01538-0718285482
   PubMed Web of Science ®Google Scholar
• Jamal W, Rotimi VO, Khodakhast F, et al. Prevalence of extended-spectrum β-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital. Med Prin Pract. 2005;14:325–331. doi:10.1159/000086930
   PubMed Web of Science ®Google Scholar
• Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D. Prevalence and antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Prin Pract. 2008;17:32–36. doi:10.1159/000109587
   PubMed Web of Science ®Google Scholar
• Kandeel A. Prevalence and risk factors of extended-spectrum β-lactamases producing Enterobacteriaceae in a general hospital in Saudi Arabia. J Microbiol Infect Dis. 2014;4(2):50–54. doi:10.5799/ahinjs.02.2014.02.0126
   Google Scholar
• Lai CC, Wu UI, Wang JT, Chang SC. Prevalence of carbapenemase-producing Enterobacteriaceae and its impact on clinical outcomes at a teaching hospital in Taiwan. JFMA. 2013;112(8):492–496.
   Google Scholar
• El Wartiti MA, Bahmani FZ, Elouennass M, Benouda A. Prevalence of carbapenemase- producing Enterobacteriaceae in a University Hospital in Rabat, Morocco: a 19-Months Prospective Study. Int Arab J Antimicrob Agents. 2012;2(3:4):1–6.
   Google Scholar
• Kandeel A. Epidemiology of carbapenemase producing Enterobacteriaceae in a general hospital. JMID. 2015;5(2):57–62. doi:10.5799/ahinjs.02.2015.02.0177
   Google Scholar
• Garbati M, Sakkijha H, Abushaheen A. Infections due to carbapenem resistant Enterobacteriaceae among Saudi Arabian hospitalized patients: a matched Case-Control Study. Biomed Res Int. 2016;2016:3961684. doi:10.1155/2016/396168427144165
   PubMed Web of Science ®Google Scholar
• Alotaibi F, Bukhari E, Al-Mohizea M, Hafiz T, Essa EB, AlTokhais YI. Emergence of carbapenem-resistant Enterobacteriaceae isolated from patients in a university hospital in Saudi Arabia. Epidemiology, clinical profiles and outcomes. J Infect Public Health. 2017;10(5):667–673. doi:10.1016/j.jiph.2017.05.00428642140
   PubMed Web of Science ®Google Scholar
• Viceconte G, Maraolo AE, Iula VD, Catania MR, Tosone G, Orlando R. Appropriateness of antibiotic prescription for targeted therapy of infections caused by multidrug-resistant bacteria: assessment of the most common improper uses in a tertiary hospital in southern Italy. Infez Med. 2017;25(3):224–233.28956539
   PubMedGoogle Scholar
• Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2014;20(9):862–872. doi:10.1111/1469-0691.1269724890393
   PubMed Web of Science ®Google Scholar
• Patolia S, Abate G, Patel N, Patolia S, Frey S. Risk factors and outcomes for multidrug- resistant gram-negative bacilli bacteremia. Ther Adv Infect Dis. 2018;5(1):11–18.29344356
   PubMed Web of Science ®Google Scholar
• Kadri SS, Adjemian J, Lai YL, et al. Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents. Clin Infect Dis. 2018;67:1803–1814.30052813
   PubMed Web of Science ®Google Scholar